HPV vaccine after treatment for vulvar high-grade lesions
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older
- You have a vulvar high-grade lesion (confirmed by a biopsy)
- You are scheduled for treatment (surgery, laser, or imiquimod cream)
- You have never had the HPV vaccine
- You do not have or have ever had HPV-related cancer (of the cervix, anus, or vulva)
- You are not pregnant, not allergic to the vaccine, and do not have HIV or a weakened immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of the HPV vaccine is enough to protect against the viruses that cause several cancers. You will have the vaccine and some small tissue samples taken to see how your immune system responds.
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.